← Leaderboards
Lynn Webster
Alltranz, Inc.
$2,081,633
Attributed
$4,238,265
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2009–19$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$4,238,265 · 2
By mechanism
RC2$4,013,265 · 1
R43$225,000 · 1
Top collaborators
- Audra L Stinchcomb2 shared
- Tassilo Baeuerle1 shared
- Marta Ceko1 shared
Others in their field
Top investigators on “Dose”
- Lawrence Corey · Fred Hutchinson Cancer Center$251,944,397
- Sharon A Nachman · Johns Hopkins University$213,337,729
- David Heimbrook · Leidos Biomedical Research, Inc.$146,807,554
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$134,297,561
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$124,321,134
- Peter C Adamson · National Childhood Cancer Foundation$122,197,823
Research focus
DoseChronic PainClinical TrialsDesignPainAffectPrototypeAdverse Drug EffectDosage FormsDrug AbuserDevelopment PlansDiffusionDeglutitionBackClinical EffectDependenceBlood CirculationCapsule (Pharmacologic)AdhesivesAdhesionsAdverse EffectsCannabinoidsCannabisCannabis Abuse
Grant awards (3)
Using Virtual Reality Psychological Therapy to Develop a Non-Opioid Chronic Pain Therapy$225,000
R43 · FY2019 · NR
Transdermal Cannabinoid Prodrug Treatment for Cannabis Withdrawal and Dependence$1,932,519
RC2 · FY2010 · DA
Transdermal Cannabinoid Prodrug Treatment for Cannabis Withdrawal and Dependence$2,080,746
RC2 · FY2009 · DA